Ambrosi Pierre, Daumas Aurélie, Villani Patrick, Giorgi Roch. Authors’ Reply to the Letter by Shoar et al. on “Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo”. Cardiology. 2020;145(6):387-387.